Vitamin D discovery could prove key to new treatments
- Details
- Category: Research
A team led by Motonari Uesugi, professor and deputy director of Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS), found that a vitamin D metabolite known as '25-OHD' inhibits proteins that regulate lipid production. Those proteins, called sterol regulatory element-binding proteins (SREBPs), cannot then stimulate expression of lipid-producing genes.
Drug shows promise for treating alcoholism
- Details
- Category: Research
UCLA researchers have found that an anti-inflammatory drug primarily used in Japan to treat asthma could help people overcome alcoholism. Their study is the first to evaluate the drug, ibudilast, as a treatment for alcoholism. Study participants were given either the drug (20 milligrams for two days and 50 milligrams for the next four) or a placebo for six consecutive days.
Mental activities may protect against mild cognitive impairment
- Details
- Category: Research
Mayo Clinic researchers have found that engaging in mentally stimulating activities, even late in life, may protect against new-onset mild cognitive impairment, which is the intermediate stage between normal cognitive aging and dementia. The study found that cognitively normal people 70 or older who engaged in computer use, craft activities, social activities and playing games had a decreased risk of developing mild cognitive impairment.
Anti-inflammatory diet could reduce risk of bone loss in women
- Details
- Category: Research
Anti-inflammatory diets - which tend to be high in vegetables, fruits, fish and whole grains - could boost bone health and prevent fractures in some women, a new study suggests. Researchers examined data from the landmark Women's Health Initiative to compare levels of inflammatory elements in the diet to bone mineral density and fractures and found new associations between food and bone health.
New genital herpes vaccine candidate provides powerful protection in preclinical tests
- Details
- Category: Research
Approximately 500 million people around the world are infected with the genital herpes virus known as herpes simplex virus 2 (HSV2). A vaccine that could bring an end to this global pandemic is needed desperately, yet no candidate vaccine has ever performed well in clinical trials. Now scientists in the Perelman School of Medicine at the University of Pennsylvania have shown that a new type of vaccine provides powerful protection in standard guinea pig and monkey models of HSV2 infection.
Too much sitting, too little exercise may accelerate biological aging
- Details
- Category: Research
Researchers at University of California San Diego School of Medicine report that elderly women who sit for more than 10 hours a day with low physical activity have cells that are biologically older by eight years compared to women who are less sedentary. The study, publishing online in the American Journal of Epidemiology, found elderly women with less than 40 minutes of moderate-to-vigorous physical activity per day and
Structure of atypical cancer protein paves way for drug development
- Details
- Category: Research
A team of researchers from Case Western Reserve University School of Medicine has helped uncover the elusive structure of a cancer cell receptor protein that can be leveraged to fight disease progression. Previous studies have showed blocking the receptor can slow tumor growth and metastasis in certain cases. However, the development of drugs (inhibitors) has been slowed by an absence of structural information on this highly unstable membrane protein.
More Pharma News ...
- Better early nutrition, better brains: Study discusses model for understanding nutrition and brain development
- Successful antibody trial in HIV-infected individuals
- Common heart drug repurposed to treat rare cancer in Europe
- New study examines the health benefits of blue corn
- Study reveals yoga may help children with cancer
- Close to half of adults and one quarter of kids in the US regularly consume artificial sweeteners
- Vaccine shows promising results for early-stage breast cancer patients